Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) EPS (Weighted Average and Diluted) (2024 - 2025)

Carlsmed (CARL) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $0.03 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 102.63% year-over-year to $0.03, compared with a TTM value of -$2.38 through Dec 2025, changed N/A, and an annual FY2025 reading of -$2.12, up 65.3% over the prior year.
  • EPS (Weighted Average and Diluted) was $0.03 for Q4 2025 at Carlsmed, down from $0.79 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.2 in Q2 2025 and bottomed at -$2.06 in Q3 2024.